Epidemiology and Infectious Diseases: Key Concepts and Measures

Epidemiology and Infectious Diseases

Disease Incidence and Prevalence

Understanding the occurrence and impact of infectious diseases in populations requires precise epidemiological measures. Two fundamental metrics are incidence and prevalence.

• Incidence: The number of new cases of a disease in a specified population during a defined period of time. Example: If 150 new cases of a disease occur in a population of 1000 people over one year, the incidence is 150 per 1000 per year.

• Prevalence: The total number of cases (both new and existing) of a disease in a population at a given time. Example: If there are 650 people with the disease (including new and existing cases) in a population of 1000, the prevalence is 650 per 1000.

Table: Calculation of Disease Incidence and Prevalence

Day	Uninfected	New cases	Existing cases
1	1000	0	0
2	850	150	150
3	350	500	650

Additional info: Table values inferred from slide example; actual numbers may vary in different scenarios.

The Scope of Disease: Endemic, Epidemic, and Pandemic

Diseases can be classified based on their occurrence and spread within populations:

• Epidemic: A disease that occurs in an unusually large number of people in a population at the same time.

• Pandemic: An epidemic that is widespread, usually affecting multiple countries or continents.

• Endemic: A disease that is constantly present, usually at low incidence, within a population.

• Reservoirs: Individuals (human or animal) that harbor the pathogen and serve as sources of infection for others.

Example: Influenza can be endemic in some regions, cause epidemics seasonally, and occasionally become pandemic (e.g., H1N1 in 2009).

Stages of Disease

The progression of infectious disease in an individual typically follows several stages:

• Infection: The pathogen invades and colonizes the host.

• Incubation period: The time between infection and the onset of symptoms.

• Acute period: The disease is at its peak severity.

• Decline period: Symptoms begin to subside as the host recovers.

• Convalescent period: The patient regains strength and returns to normal health.

Example: In measles, the incubation period is about 10 days, followed by acute symptoms such as fever and rash.

Mortality, Morbidity, and Disability-Adjusted Life Year (DALY)

These measures help quantify the impact of infectious diseases on populations:

• Mortality: The incidence of death in a population due to a specific disease.

• Morbidity: The incidence of disease (both fatal and nonfatal cases) in a population.

• Disability-Adjusted Life Year (DALY): A quantitative measure of disease burden, combining years of life lost due to premature death and years lived with disability. $\text{DALY} = \text{Years of Life Lost (YLL)} + \text{Years Lived with Disability (YLD)}$

Example: A disease with low mortality but high morbidity (e.g., chronic hepatitis) can have a high DALY due to long-term disability.

Major Causes of Death Due to Infectious Diseases

Infectious diseases remain a leading cause of death worldwide. The following table summarizes the main diseases, their contribution to global mortality, and their causative agents:

Disease	Deaths (% of deaths from all infectious diseases)	Causative Agents
Respiratory infections	31	Bacteria, viruses, fungi
Diarrheal diseases	15	Bacteria, viruses
Acquired immunodeficiency syndrome (AIDS)	13	Virus
Tuberculosis	15	Bacterium
Malaria	6	Protist
Measles	3	Virus
Meningitis, bacterial	2	Bacterium
Pertussis (whooping cough)	2	Bacterium
Tetanus	1	Bacterium
Hepatitis (all types)	1	Virus
Other communicable diseases	11	Various agents

Additional info: Table adapted from global health statistics; percentages may vary by year and region.

The Host Community: Coevolution of Host and Pathogen

Host-pathogen interactions are dynamic and can lead to coevolution, affecting disease outcomes and transmission patterns.

• Coevolution: The reciprocal evolutionary adaptations of hosts and their pathogens.

• Virulence and Transmission: Over time, the virulence of a pathogen may decrease if high virulence reduces transmission opportunities (e.g., myxoma virus in Australian rabbits).

• Host Resistance: Host populations may evolve increased resistance to pathogens.

• Non-host Transmission: Pathogens not reliant on host-to-host transmission (e.g., Escherichia coli in hospitals) may remain highly virulent.

Example: The introduction of myxoma virus to control rabbit populations in Australia led to decreased virus virulence and increased rabbit resistance over time.

Herd Immunity

Herd immunity is a critical concept in public health, describing the resistance of a group to infection due to immunity in a high proportion of individuals.

• If a large percentage of the population is immune (through vaccination or previous infection), the spread of the disease is limited, protecting even those who are not immune.

• Immunized individuals act as barriers, breaking the chain of transmission.

Example: Measles outbreaks are prevented in communities with high vaccination coverage due to herd immunity.

Additional info: The threshold for herd immunity depends on the basic reproduction number ($R_0$) of the pathogen; for measles, over 90% immunity is required.